Home » Stocks » TNDM

Tandem Diabetes Care, Inc. (TNDM)

Stock Price: $92.73 USD 1.50 (1.64%)
Updated Jun 16, 2021 2:55 PM EDT - Market open
Market Cap 5.80B
Revenue (ttm) 541.94M
Net Income (ttm) -24.56M
Shares Out 62.45M
EPS (ttm) -0.40
PE Ratio n/a
Forward PE 1,111.11
Dividend n/a
Dividend Yield n/a
Trading Day June 16
Last Price $92.73
Previous Close $91.23
Change ($) 1.50
Change (%) 1.64%
Day's Open 91.19
Day's Range 90.71 - 93.25
Day's Volume 250,905
52-Week Range 76.19 - 123.74

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

These two companies are less volatile than the cryptocurrency, and they offer better long-term prospects, too.

Other stocks mentioned: VEEV
3 days ago - The Motley Fool

Data presented at the ATTD conference demonstrates Tandem Diabetes Care's (TNDM) Control-IQ technology's ability to make a positive and sustained impact on diabetes care.

5 days ago - Zacks Investment Research

SAN DIEGO--(BUSINESS WIRE)---- $TNDM--Tandem Diabetes Care announced positive real-world data from Control-IQ advanced hybrid closed-loop technology at international diabetes conference.

1 week ago - Business Wire

Tandem Diabetes Care, Inc. (TNDM) reported earnings 30 days ago. What's next for the stock?

1 week ago - Zacks Investment Research

Investors continue to be optimistic about Tandem Diabetes (TNDM) on strong quarterly results and robust pump sales.

4 weeks ago - Zacks Investment Research

Tandem Diabetes (TNDM) is witnessing high international demand for the t:slim X2 pump.

1 month ago - Zacks Investment Research

Tandem Diabetes' (TNDM) strong international and domestic pump sales and shipment boosted the first-quarter top line.

1 month ago - Zacks Investment Research

Tandem Diabetes Care, Inc. (TNDM) delivered earnings and revenue surprises of 53.33% and 14.98%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

1 month ago - Zacks Investment Research

SAN DIEGO--(BUSINESS WIRE)---- $TNDM #ControlIQ--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today reported its financial results for the quart...

1 month ago - Business Wire

SAN DIEGO--(BUSINESS WIRE)---- $TNDM #TNDM--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company ...

1 month ago - Business Wire

Tandem Diabetes Care, Inc. (TNDM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 month ago - Zacks Investment Research

LUCERNE, Switzerland & MARLBOROUGH, Mass.--(BUSINESS WIRE)-- #CeQur--CeQur®, a medical device company committed to simplifying the lives of people with diabetes by revolutionizing insulin-delivery solut...

2 months ago - Business Wire

SAN DIEGO--(BUSINESS WIRE)---- $TNDM--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its first quarter 2021 results after the fin...

2 months ago - Business Wire

Tandem Diabetes Care, Inc. (TNDM) reported earnings 30 days ago. What's next for the stock?

2 months ago - Zacks Investment Research

Investors continue to be optimistic about Tandem Diabetes (TNDM) on robust pump sales and shipments.

2 months ago - Zacks Investment Research

Here are a few diabetes-centric MedTech stocks, ABT, NVO, MDT, PODD and TNDM, which investors can focus on to reap profits in the new normal.

Other stocks mentioned: ABT, MDT, NVO, PODD
2 months ago - Zacks Investment Research

Both of these companies have a long runway for growth.

Other stocks mentioned: FB
2 months ago - The Motley Fool

Tandem Diabetes (TNDM) is expects t:sport to be a major growth catalyst for 2022.

3 months ago - Zacks Investment Research

SAN DIEGO--(BUSINESS WIRE)---- $TNDM--Tandem Diabetes Care today announced the appointment of Jordan Pinsker, MD, to Vice President and Medical Director, effective April 26, 2021.

3 months ago - Business Wire

Tandem Diabetes' (TNDM) strong domestic and international pump sales and shipments boosted the Q4 top line.

3 months ago - Zacks Investment Research

SAN DIEGO--(BUSINESS WIRE)---- $TNDM #ControlIQ--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today reported its financial results for the quart...

3 months ago - Business Wire

On Wednesday, February 24, Tandem Diabetes Care (NASDAQ:TNDM) will report its last quarter's earnings. Here is Benzinga's preview of the company's release.

3 months ago - Benzinga

Tandem Diabetes Care, Inc. (TNDM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

3 months ago - Zacks Investment Research

SAN DIEGO--(BUSINESS WIRE)---- $TNDM #TNDM--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company ...

3 months ago - Business Wire

SAN DIEGO--(BUSINESS WIRE)---- $TNDM--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its fourth quarter and full year 2020 result...

4 months ago - Business Wire

These two providers of diabetes-related products and services have yet to scratch the surface of their potential.

Other stocks mentioned: DXCM
5 months ago - The Motley Fool

Up 50% in 2020 with significant upside still ahead, Tandem Diabetes Care has a long runway for growth.

5 months ago - The Motley Fool

Investors continue to be optimistic about Tandem Diabetes (TNDM) on robust pump sales and shipments.

6 months ago - Zacks Investment Research

SAN DIEGO--(BUSINESS WIRE)---- $TNDM--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced the appointment of Rajwant (Raj) Singh Sodhi ...

Other stocks mentioned: RMD
6 months ago - Business Wire

Tandem Diabetes' (TNDM) t:slim X2 Insulin Pump with Control-IQ Advanced Hybrid Closed-Loop Technology cleared for use in Canada post the receipt of Health Canada approval.

6 months ago - Zacks Investment Research

SAN DIEGO--(BUSINESS WIRE)-- #ControlIQ--Tandem Diabetes Care today announced Health Canada approval of the t:slim X2™ insulin pump with Control-IQ™ technology.

6 months ago - Business Wire

Tandem Diabetes' (TNDM) strong domestic pump sales and pump shipments boosted the top line.

7 months ago - Zacks Investment Research

At present, the New York Times (NYT), Apple (AAPL) and Tandem Diabetes Care (TNDM) are some of the few companies boasting solid earnings acceleration.

Other stocks mentioned: AAPL, NYT
7 months ago - Zacks Investment Research

Tandem Diabetes Care, Inc. (TNDM) CEO John Sheridan on Q3 2020 Results - Earnings Call Transcript

7 months ago - Seeking Alpha

SAN DIEGO--(BUSINESS WIRE)---- $TNDM #ControlIQ--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today reported its financial results for the quart...

7 months ago - Business Wire

SAN DIEGO--(BUSINESS WIRE)---- $TNDM--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update...

7 months ago - Business Wire

This diabetes-focused healthcare company and financial services giant are ready to reward their shareholders.

Other stocks mentioned: SQ
7 months ago - The Motley Fool

SAN DIEGO--(BUSINESS WIRE)---- $TNDM--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its third quarter 2020 results after the fin...

8 months ago - Business Wire

The U.S. presidential election is less than 50 days away and the health care sector could prove to be the most impacted. On Monday, Chantico Global CEO Gina Sanchez laid out on CNBC’s “Trading Nation” h...

Other stocks mentioned: STE
8 months ago - Invezz

These three stocks are among the few winners to emerge from the coronavirus stock market.

Other stocks mentioned: ABT, VRTX
9 months ago - The Motley Fool

SAN DIEGO--(BUSINESS WIRE)---- $TNDM #TNDM--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that John Sheridan, president and chief...

9 months ago - Business Wire

Per the DCLP5 study, Tandem Diabetes' (TNDM) insulin pump with Control-IQ technology suitable for use in children aged six to 13 years, which has been published in the NEJM.

9 months ago - Zacks Investment Research

SAN DIEGO--(BUSINESS WIRE)---- $TNDM #ControlIQ--Tandem announces New England Journal of Medicine publication of pediatric study showing increased time in range with Control-IQ technology.

9 months ago - Business Wire

DexCom, Tandem Diabetes, and Novo Nordisk have plenty of momentum and growth ahead, making them excellent buys this month.

Other stocks mentioned: DXCM, NVO
10 months ago - The Motley Fool

Tandem Diabetes Care: Gaining Share In A Growing Market

10 months ago - Seeking Alpha

Tandem Diabetes' (TNDM) strong domestic pump sales and pump shipments boosted the top line.

10 months ago - Zacks Investment Research

Tandem Diabetes Care's (TNDM) CEO John Sheridan on Q2 2020 Results - Earnings Call Transcript

10 months ago - Seeking Alpha

SAN DIEGO--(BUSINESS WIRE)---- $TNDM #ControlIQ--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today reported its financial results for the quart...

10 months ago - Business Wire

SAN DIEGO--(BUSINESS WIRE)---- $TNDM--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced the appointment of Peyton Howell as an indepe...

10 months ago - Business Wire

With so much focus and attention geared toward the novel coronavirus and the COVID-19 pandemic, health care has been affected in many strange ways.

Other stocks mentioned: DVA, ISRG, MDT, OMI, ONEM, WBA
10 months ago - 24/7 Wall Street

About TNDM

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin cartridge, and an infusion set. It also provides t:slim X2 insulin with Basal-IQ and control IQ technology; t:slim X2 with G5 Integration; and Tandem Device Updater, a tool that allows users to update their pump's software. ... [Read more...]

Industry
Medical Devices
IPO Date
Nov 14, 2013
CEO
John Sheridan
Employees
1,500
Stock Exchange
NASDAQ
Ticker Symbol
TNDM
Full Company Profile

Financial Performance

In 2020, TNDM's revenue was $498.83 million, an increase of 37.68% compared to the previous year's $362.31 million. Losses were -$34.38 million, 38.9% more than in 2019.

Financial Statements

Analyst Forecasts

According to 15 analysts, the average rating for TNDM stock is "Buy." The 12-month stock price forecast is 125.06, which is an increase of 34.86% from the latest price.

Price Target
$125.06
(34.86% upside)
Analyst Consensus: Buy